Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,760.60
2,041.53
2,054.23
1,565.59
1,294.36
1,591.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,760.60
2,041.53
2,054.23
1,565.59
1,294.36
1,591.29
Raw Material Cost
1,570.79
1,803.62
1,598.37
1,062.67
816.79
1,025.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
135.46
111.77
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.74
14.77
3.41
3.41
16.27
36.57
Selling and Distribution Expenses
79.45
90.36
96.16
96.37
80.41
122.98
Other Expenses
4.32
5.11
5.75
-9.29
-8.51
1.40
Total Expenditure (Excl Depreciation)
1,707.14
1,959.84
1,755.43
1,204.98
940.16
1,199.49
Operating Profit (PBDIT) excl Other Income
53.5
81.7
298.8
360.6
354.20000000000005
391.8
Other Income
60.45
62.01
52.61
9.08
-0.70
-23.65
Operating Profit (PBDIT)
275.35
278.64
408.19
441.31
415.84
431.68
Interest
13.74
14.77
3.41
3.41
16.27
36.57
Exceptional Items
5.45
4.15
0.00
-7.26
-7.51
73.57
Gross Profit (PBDT)
189.80
237.91
455.87
502.92
477.57
565.32
Depreciation
181.99
161.32
95.94
75.81
70.47
73.35
Profit Before Tax
85.07
106.70
308.83
354.83
321.59
395.32
Tax
8.23
11.39
43.18
51.19
48.44
62.78
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.47
87.17
434.80
493.85
257.18
313.83
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.47
87.17
434.80
493.85
257.18
313.83
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.46
87.17
434.80
493.85
257.18
313.83
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,360.68
4,359.84
2,113.95
1,677.98
1,184.24
927.15
Earnings per share (EPS)
0.13
0.22
1.09
1.23
0.64
0.78
Diluted Earnings per share
0.13
0.22
1.09
1.23
0.64
0.78
Operating Profit Margin (Excl OI)
1.87%
2.71%
12.64%
22.77%
26.74%
24.0%
Gross Profit Margin
15.17%
13.13%
19.7%
27.51%
30.29%
29.45%
PAT Margin
2.92%
4.27%
21.17%
31.54%
19.87%
19.72%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -13.76% vs -0.62% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -40.94% vs -79.94% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -0.78% vs -39.09% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -7.43% vs 335.29% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Hubei Hongyuan Pharmaceutical Technology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,760.60
0
1,760.60
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,760.60
0
1,760.60
Raw Material Cost
1,570.79
0
1,570.79
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.74
0
13.74
Selling and Distribution Expenses
79.45
0
79.45
Other Expenses
4.32
0.00
4.32
Total Expenditure (Excl Depreciation)
1,707.14
0
1,707.14
Operating Profit (PBDIT) excl Other Income
53.46
0.00
53.46
Other Income
60.45
0
60.45
Operating Profit (PBDIT)
275.35
0
275.35
Interest
13.74
0
13.74
Exceptional Items
5.45
0
5.45
Gross Profit (PBDT)
189.80
0
189.80
Depreciation
181.99
0
181.99
Profit Before Tax
85.07
0
85.07
Tax
8.23
0
8.23
Provisions and contingencies
0
0
0.00
Profit After Tax
51.47
0
51.47
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
51.47
0
51.47
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.00
0
-0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.46
0
51.46
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,360.68
0
4,360.68
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
1.87%
0%
0.00
1.87%
Gross Profit Margin
15.17%
0%
0.00
15.17%
PAT Margin
2.92%
0%
0.00
2.92%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 176.06 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -13.76% vs -0.62% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 5.15 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -40.94% vs -79.94% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21.49 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -0.78% vs -39.09% in Dec 2023
Annual - Interest
Interest 1.37 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -7.43% vs 335.29% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.87%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






